Elena Rybakina to Withdraw from US Open 2026? Left Heel Tendon, the World No.1 Race, and a Controversial Decision

Cincinnati, the last hard court before the US Open. First set, score 1-4. Elena Rybakina steps to her left to receive a return from Iga Swiatek, then suddenly stops. She bends down, touches her left heel. The umpire approaches, a brief consultation takes place at the sideline. Then she nods, continues playing — one more service game — before realizing her body no longer obeys her will. Retirement. Not because she lost the point, but because she could not move. That moment encapsulates the question hanging over Elena Rybakina ahead of the US Open 2026: will she compete in the season's final Grand Slam? And if she does, what will she play with when the left heel tendon — the foundation of every movement on hard courts — is in a state of alarm? According to ESPN, the issue is identified as a tendon injury in the left heel. What matters is the distinction: this is not an Achilles injury — at least, there is no official confirmation of that. The "Achilles issue" label is speculation from the media, with no diagnostic value. But regardless of which tendon, one fact is undeniable: Rybakina could not finish her match against Swiatek in Cincinnati, and she has withdrawn from the mixed doubles at the US Open 2026. The context makes this story far more complex than a routine injury case. Rybakina stands before the opportunity to claim the World No. 1 ranking — but the condition is reaching the US Open semi-final. This is not an optional goal; it is a survival-level arithmetic calculation in the ranking race. A Grand Slam semi-final means seven matches, seven times stepping onto the court over two weeks, at the highest physical intensity tennis can demand. I have followed Rybakina since her ITF days in Europe, before she won Wimbledon 2026. What sets her apart is not her powerful serve or flat forehand — things any top-20 player possesses — but her ability to finish points from a very deep court position. She does not need to move much to win points, but when she must move, she needs explosive power from her legs. And that is exactly what is injured. The Cincinnati match against Swiatek leaves a severe data gap. Rybakina retired while trailing 1-4 in the first set — there is almost no time to assess whether her service rhythm, return position, or baseline footwork were still functional. We do not know if she was serving at her usual speed, or if she was avoiding movement to her left. No match statistics from that match can answer these questions. This is an information black hole before a Grand Slam — the worst scenario for any analyst. The injury tracking system was born from Covid, but it lives for ordinary days. I built a personal database for 126 European players during the 2026 shutdown, and I know the value of continuous data. With Rybakina, the data gap from Cincinnati makes every prediction about her US Open form fragile. We have only one fact: she could not move her left leg during the match against Swiatek. One detail many overlook: the strapping around the heel area visible in pre-match images at Cincinnati. This suggests the problem may have existed before, not suddenly emerging during the Swiatek match. If so, Rybakina's team had been trying to manage the injury with strapping and load-reduction measures — and failed. This is a worrying signal, because it indicates a cumulative injury, not a single incident. What troubles me most is the decision to "play on and reassess after one more service game." On the positive side, that is the mentality of a champion — refusing to quit before truly exhausted. But from a sports medicine perspective, it is a concerning decision. A player who cannot move her leg — literally — should not continue, unless the medical team has confirmed there is no risk of further damage. The article does not mention whether Rybakina received medical clearance to continue. Without that clearance, playing one more game only increases the risk of worsening the injury. This is the blind spot I want to emphasize: in modern tennis, the line between "courage" and "recklessness" is often blurred by ranking pressure. Rybakina stands before the World No. 1 opportunity — an opportunity any player craves. But the question is: is chasing that opportunity worth risking a long-term career? I have witnessed too many rushed returns from injury — not only in tennis but also in football — and most paid the price in the later stages of their careers. The psychological fear after injury is far harder to fix than the physical damage. Tactically, if Rybakina does enter the US Open, her top priority will be shortening points. Serve-plus-one patterns — a powerful serve followed by a flat forehand or backhand finish — would become her primary weapon, reducing reliance on sustained lateral movement. But this is my speculation based on tactical logic, not from any information in the article. And even with point-shortening tactics, seven matches at a Grand Slam remains an enormous physical workload. The hard courts at Flushing Meadows are notorious for demanding stopping and pushing-off movements — exactly the actions that place the greatest stress on the heel. Rybakina's withdrawal from the US Open mixed doubles is a significant signal. If she had only a minor issue, keeping the mixed doubles schedule would be normal — mixed doubles runs alongside singles, and withdrawing suggests her team is trying to minimize load on the left leg. This reinforces the hypothesis that the injury is more serious than the public has been told. I remember the 2026 World Cup, when I was criticized for being too dry in my commentary of the France - Croatia final. The lesson I learned: data needs a heart to become a story. For Rybakina, the story is not just a tendon injury — it is a 27-year-old player at the peak of her career, facing a choice between chasing the World No. 1 ranking now, or protecting her body to extend her career. This is a problem with no absolutely correct answer. From my perspective, after 37 years of watching elite sport, I have learned that the most hasty decisions come from time pressure. The US Open 2026 is Rybakina's only chance to claim the No. 1 spot this year — but if she cannot compete at 100%, that opportunity could become a trap. Seven matches at the highest intensity, on hard courts, with an injured heel tendon — that is a recipe for a long-term disaster. The final question is not "will Rybakina withdraw from the US Open," but "will Rybakina be wise enough to know when to stop." And the answer to that question will shape not only her 2026 season, but the rest of her career.